Prostate fluid particles may hold key to smarter cancer detection
NCT ID NCT07355985
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looked at tiny particles called extracellular vesicles (EVs) found in prostate fluid from 100 men. The goal was to find unique molecular signatures that could help tell aggressive prostate cancer from slow-growing or benign conditions. Researchers used advanced techniques to analyze proteins, fats, and other molecules in these particles. The findings could lead to better, less invasive ways to diagnose and monitor prostate cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BENIGN PROSTATIC HYPERTROPHY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- A sharper eye on prostate cancer: could new imaging spare healthy tissue?
- Can a new drug combo tame resistant prostate cancer?
- Virtual cooking classes aim to boost health for hispanic prostate cancer survivors and their families
- Prostate Surgery's hidden toll: study probes lasting impact on Men's lives
- Which gas pump causes less pain during robotic prostate surgery? a Head-to-Head trial
- Nerve-Sparing radiation may help men keep sexual function after prostate cancer treatment